Affymax Inc (OTCQB:AFFY.PK)

Data as of 3:12pm ET
 -0.012 / -7.06%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Affymax, Inc. is a biopharmaceutical company that is discovering, developing and delivering innovative therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses. It has developed OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. The company is building a pipeline of novel peptide drugs against clinically validated targets that will provide product profiles over therapeutic proteins. Affymax was founded on July 20, 2001 and is headquartered in Palo Alto, CA.

Contact Information

Affymax, Inc.
19200 Stevens Creek Boulevard
Cupertino California 95014
P:(650) 812-8700
Investor Relations:



Individual stakeholders9.93%
Mutual fund holders1.77%
Other institutional1.12%

Top Executives

Richard M. BrennerChief Executive Officer & Director
J. Weston RosePresident
Andrew T. BlairVice President-Medical Affairs
Tim VaracekVice President-Sales & Account Management
Kay SlocumSenior Vice President-Human Resources

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.